As global markets react to economic data and shifting investor sentiment, the Hong Kong market has seen its own share of fluctuations. Despite these challenges, opportunities for finding undervalued stocks remain present in the SEHK. In this environment, a good stock often demonstrates strong fundamentals and resilience against broader market volatility.
Name | Current Price | Fair Value (Est) | Discount (Est) |
Best Pacific International Holdings (SEHK:2111) | HK$2.18 | HK$4.34 | 49.7% |
Bosideng International Holdings (SEHK:3998) | HK$3.90 | HK$6.78 | 42.5% |
ANTA Sports Products (SEHK:2020) | HK$68.80 | HK$136.45 | 49.6% |
BYD Electronic (International) (SEHK:285) | HK$28.30 | HK$53.03 | 46.6% |
Shanghai INT Medical Instruments (SEHK:1501) | HK$28.20 | HK$56.15 | 49.8% |
Pacific Textiles Holdings (SEHK:1382) | HK$1.62 | HK$2.99 | 45.8% |
iDreamSky Technology Holdings (SEHK:1119) | HK$2.24 | HK$4.22 | 46.9% |
Weimob (SEHK:2013) | HK$1.19 | HK$2.18 | 45.5% |
Innovent Biologics (SEHK:1801) | HK$41.15 | HK$73.85 | 44.3% |
MicroPort CardioFlow Medtech (SEHK:2160) | HK$0.77 | HK$1.38 | 44.2% |
Let's dive into some prime choices out of the screener.
Overview: Pacific Textiles Holdings Limited manufactures and trades textile products across various international markets, with a market cap of approximately HK$2.26 billion.
Operations: The company generates HK$4.67 billion in revenue from the manufacturing and trading of textile products.
Estimated Discount To Fair Value: 45.8%
Pacific Textiles Holdings is trading at HK$1.62, significantly below its estimated fair value of HK$2.99, suggesting it may be undervalued based on cash flows. Despite a forecasted annual earnings growth of 37.67%, profit margins have declined from 5.4% to 3.6%. Recent amendments to company bylaws aim to align with regulatory changes, and the proposed final dividend is HKD 0.05 per share for FY2024, despite a notable drop in net income from HKD 268.57 million to HKD 167.12 million year-over-year.
Overview: Shanghai INT Medical Instruments Co., Ltd. (SEHK:1501) operates in the medical instruments sector and has a market cap of HK$4.94 billion.
Operations: The company's revenue from the Cardiovascular Interventional Business is CN¥641.32 million.
Estimated Discount To Fair Value: 49.8%
Shanghai INT Medical Instruments is trading at HK$28.2, well below its estimated fair value of HK$56.15, indicating significant undervaluation based on cash flows. Despite past shareholder dilution, earnings are projected to grow significantly at 25.41% annually over the next three years, outpacing the Hong Kong market's growth rate. The company recently approved a final dividend of HKD 0.30 per share for FY2023, reflecting solid financial health and commitment to returning value to shareholders.
Overview: Techtronic Industries Company Limited designs, manufactures, and markets power tools, outdoor power equipment, and floorcare and cleaning products globally, with a market cap of HK$179.04 billion.
Operations: Techtronic Industries generates revenue from power tools, outdoor power equipment, and floorcare and cleaning products across North America, Europe, and international markets.
Estimated Discount To Fair Value: 10.4%
Techtronic Industries, trading at HK$97.7, is undervalued based on cash flows with an estimated fair value of HK$109.01. Earnings are forecast to grow 15.16% annually, outpacing the Hong Kong market's 11.3% growth rate, although revenue growth is slower at 8.5%. Recent earnings showed net income rising to US$550.37 million from US$475.78 million year-over-year and an interim dividend of HKD1.08 per share was announced for H1 2024.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com